US Food and Drug Administration regulatory updates in neuro-oncology

OBJECTIVE: Contemporary management of patients with neuro-oncologic disease requires an understanding of approvals by the US Food and Drug Administration (FDA) related to nervous system tumors. To summarize FDA updates applicable to neuro-oncology practitioners, we sought to review oncology product...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Gautam U., Barone, Amy K., Bradford, Diana, Larkins, Erin, Kim, Janice, Pai-Scherf, Lee, Jaigirdar, Adnan, Shah, Mirat, Wedam, Suparna, Amiri-Kordestani, Laleh, Theoret, Marc R., Pazdur, Richard, Beaver, Julia A., Singh, Harpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218275/
https://www.ncbi.nlm.nih.gov/pubmed/34156585
http://dx.doi.org/10.1007/s11060-021-03789-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218275/
https://www.ncbi.nlm.nih.gov/pubmed/34156585
http://dx.doi.org/10.1007/s11060-021-03789-5

Ejemplares similares